| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gumulka Jerzy is a Director at CNS Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $237K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 33,333 | $0.30 | $9,999.90 | +344.6% | -13.7% | -99.2% | |
| Apr 19, 2023 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 2,500 | $1.70 | $4,250.00 | +34.9% | +18.6% | -88.5% | |
| Apr 10, 2023 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 7,173 | $0.74 | $5,308.02 | New | +224.3% | -69.4% |